Health
Competitive multiplex binding assay can monitor SARS-CoV-2 immune responses using nanobodies – News-Medical.Net
Researchers at the Eberhard Karls University and the University of Tübingen in Germany described 11 unique nanobodies (Nbs) specific for the SARS-CoV-2 spike receptor-binding…
Measuring the presence and performance of neutralizing antibodies is crucial in the fight against the coronavirus disease 2019 (COVID-19) pandemic. This allows us to glimpse how effective vaccines and antibody therapies are in conferring protective immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Researchers in Germany and the U.S. described 11 unique nanobodies (Nbs) specific for the SARS-CoV-2 spike receptor-binding domain (RBD), of which 8 Nbs potentially inhibit…
-
General13 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News17 hours agoWest End icon closes doors
-
General19 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay
-
Noosa News23 hours agoIs Auckland New Zealand’s New Cultural Capital?